Skip to Main Content

Paper Details

TP53, CDKN2A/P16, and NFE2L2/NRF2 regulate the incidence of pure- and combined-small cell lung cancer in mice.
Oncogene
6
2022
C, C-SCLC, C-SCLCs, CDKN2A, Cre, GEMM, LSL-, LSL-Nrf2 allele, Mice, NE, NE-lung tumors, NFE2L2, NKX1-2, NRF2, NRF2 mutation, NRF2 pathway signature, Nrf2, Nrf2 allele, P, P-, P-SCLC, P-SCLCs, P16, P63, SCLC, TP53, Trp53, cancer, combined-small cell lung cancer, consensus, human, human tumors, large, large cell neuroendocrine carcinoma, lung cancer, lung tumor, lung tumors, mice, mouse, p16, pure- and combined-small cell lung cancer, pure-SCLC, tumor, tumors
Author NameAffiliation
Stephanie A MontgomeryLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine
Stephanie A MontgomeryUniversity of North Carolina at Chapel Hill School of Medicine
Jeremy M SimonLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine
Jeremy M SimonUniversity of North Carolina at Chapel Hill School of Medicine
Jeremy M SimonUniversity of North Carolina at Chapel Hill School of Medicine
Scott H RandellMarsico Lung Institute, University of North Carolina at Chapel Hill School of Medicine
David Neil HayesUniversity of Tennessee Health Science Center for Cancer Research, University of Tennessee
David Neil HayesUniversity of Tennessee Health Science Center for Cancer Research, University of Tennessee
Trudy G OliverUniversity of Utah
Michael B MajorLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine
Michael B MajorUniversity of North Carolina at Chapel Hill School of Medicine
Michael B MajorLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine
Michael B MajorUniversity of North Carolina at Chapel Hill School of Medicine
  • 1 - 13

Datasets